SPECIFIC BIOLOGICS Trademark

Trademark Overview

On Wednesday, August 5, 2020, a trademark application was filed for SPECIFIC BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the SPECIFIC BIOLOGICS trademark a serial number of 90095102. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 27, 2022. This trademark is owned by Specific Biologics Inc.. The SPECIFIC BIOLOGICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical treatment of genetic diseases and disorders, cystic fibrosis and cancer
specific biologics

General Information

Serial Number90095102
Word MarkSPECIFIC BIOLOGICS
Filing DateWednesday, August 5, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 27, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements

Goods and ServicesMedical treatment of genetic diseases and disorders, cystic fibrosis and cancer
Disclaimer with Predetermined Text"BIOLOGICS"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 3, 2020
Primary Code044
First Use Anywhere DateWednesday, May 31, 2017
First Use In Commerce DateSaturday, June 10, 2017

Trademark Owner History

Party NameSpecific Biologics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G0B7
CA
Party NameSpecific Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G0B7
CA

Trademark Events

Event DateEvent Description
Thursday, October 27, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 27, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, October 27, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, April 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 2, 2022NON-FINAL ACTION E-MAILED
Saturday, April 2, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, February 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 22, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 15, 2022USE AMENDMENT FILED
Tuesday, February 22, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 15, 2022SOU EXTENSION 1 FILED
Tuesday, February 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, December 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 17, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, May 19, 2021DIVISIONAL REQUEST RECEIVED
Thursday, June 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 19, 2021TEAS REQUEST TO DIVIDE RECEIVED
Sunday, November 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 29, 2020NON-FINAL ACTION E-MAILED
Sunday, November 29, 2020NON-FINAL ACTION WRITTEN
Saturday, November 28, 2020ASSIGNED TO EXAMINER
Thursday, September 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 31, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sunday, August 30, 2020ASSIGNED TO LIE
Monday, August 10, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, August 8, 2020NEW APPLICATION ENTERED

Related Keywords

biologics specific cystic fibrosis cancer disorders diseases treatment genetic medical